Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
REVAC-B+
- Development stage
- Unknown
- Lead developer
- Bharat Biotech
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
REVAC-B+ (Revac-B Plus) is a recombinant hepatitis B vaccine developed and manufactured by Bharat Biotech. It consists of highly purified hepatitis B surface antigen (HBsAg) produced by recombinant DNA technology in yeast (*Saccharomyces cerevisiae*). The vaccine is adsorbed onto aluminum hydroxide, which serves as an adjuvant to enhance the immune response. REVAC-B+ is indicated for active immunization against infection caused by all known subtypes of the hepatitis B virus (HBV) in individuals of all ages, including neonates, infants, children, and adults. It works by inducing the production of specific protective antibodies (anti-HBs) against the viral surface protein, providing long-term immunity against HBV and its associated complications, such as cirrhosis and hepatocellular carcinoma.
- Brand names
- REVAC-B+Revac-B Plus
- Other names
- Hepatitis B vaccine (recombinant)
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on REVAC-B+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on REVAC-B+.